🇺🇸 FDA
Patent

US 12383629

DNA-affibody-drug nanoparticles for inhibiting the metastasis of cancer cells overexpressing HER2

granted A61KA61K31/65A61K38/00

Quick answer

US patent 12383629 (DNA-affibody-drug nanoparticles for inhibiting the metastasis of cancer cells overexpressing HER2) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/65, A61K38/00, A61K47/549, A61K47/64